Usability, safety and tolerability of CUE1 vibrotactile device as promising therapeutic approach in orthostatic tremor
CUE1 vibrotactile stimulation is safe, well-tolerated, and shows promise in improving balance, mobility, and fatigue in POT. Larger, controlled trials are warranted.
Authors
- Cristina Simonet (ORCID: https://orcid.org/0000-0002-5555-0283)
- Alastair John Noyce (ORCID: https://orcid.org/0000-0003-3027-5497)
- Thomas Boyle
- Alexandra Zirra (ORCID: https://orcid.org/0000-0003-3901-5456)
- David A. Gallagher
- Viktoria Azoidou (ORCID: https://orcid.org/0009-0003-3613-4764)
Institutions
- Queen Mary University of London (GB)
- Barts Health NHS Trust (GB)
- Royal London Hospital (GB)
- Homerton University Hospital NHS Foundation Trust (GB)
Publication Details
- Journal
- Clinical Parkinsonism & Related Disorders
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.prdoa.2025.100379
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00